Ribavirin: an antiviral agent with promise
Mack, J.E.
Pediatric Nursing 14(3): 220-221
1988
ISSN/ISBN: 0097-9805 PMID: 3380572 Document Number: 323515
Document emailed within 1 workday
Related Documents
Tsilevich, T.L.; Shchaveleva, I.L.; Nosach, L.N.; Zhovnovataia, V.L.; Smirnov, I.P. 1988: Acyclic analogs of ribavirin. Synthesis and antiviral activity Bioorganicheskaia Khimiia 14(5): 689-693Lagrota, M.H.; Ciribelli-Guimaräes, J.; Pereira, N.A.; Wigg, M.D.; Fonseca, M.E. 1982: Antiviral chemotherapy: in vitro activity of ribavirin on DNA and RNA viruses Revista Latinoamericana de Microbiologia 24(2): 121-124
Il'icheva, T.N.; Kulishova, L.A.; Shul'ts, E.E.; Petrenko, N.I.; Uzenkova, N.V.; Ias'ko, M.V.; Serova, O.A.; Volkov, G.N.; Belanov, E.F.; Tolstikov, G.A.; Pokrovskiĭ, A.G. 2005: Antiviral activity of vegetable triterpens, their derivatives and ribavirin phosphonates Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(2): 26-30
Chen, X.-x.; Zhou, H.-x.; Qi, W.-b.; Ning, Z.-y.; Ma, Y.-j.; Li, Y.-l.; Wang, G.-c.; Chen, J.-x. 2015: Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza a H1N1 virus infection in vivo Yao Xue Xue Bao 50(8): 966-972
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Tsapkina, E.N.; Gurskaia, G.V.; Zavgorodniĭ, S.G.; Lindeman, S.V.; Struchkov, I.T. 1988: The structure and antiviral activity of ribavirin analogs. II. Molecular and crystal structure of 1-(1,5-dihydroxy-3-oxapent-2-yl)-1,2,4-triazole-5-carboxamide Bioorganicheskaia Khimiia 14(8): 1092-1097
Inglot, A.D. 1980: Interferon as an antiviral, antineoplastic and immunomodulating agent Postepy Higieny i Medycyny Doswiadczalnej 34(2): 89-105
Galegov, G.A.; Litvin, A.A. 2007: Panavir, as a broad spectrum antiviral agent Antibiotiki i Khimioterapiia 52(9-10): 45-49
Schulman, J.; Peyman, G.A.; Horton, M.B.; Liu, J.; Barber, J.C.; Fiscella, R.; de Miranda, P. 1986: Intraocular penetration of new antiviral agent, hydroxyacyclovir (BW-B759U) Japanese Journal of Ophthalmology 30(1): 116-124
Roberts, R.B.; Dickinson, G.M.; Heseltine, P.N.; Leedom, J.M.; Mansell, P.W.; Rodriguez, S.; Johnson, K.M.; Lubina, J.A.; Makuch, R.W. 1990: A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. the Ribavirin-LAS Collaborative Group Journal of Acquired Immune Deficiency Syndromes 3(9): 884-892
2003: New antiviral agent. Hepatitis B therapy with slight resistance risk MMWFortschrittederMedizin 145(51-52): 40
Peteri, D.; Sterner, W. 1973: Chemistry and toxicology of a new antiviral agent: N-(1-adamantyl)-2-(2-dimethylamino-ethoxy)-acetamide-HCl.1 Arzneimittel-Forschung 23(4): 577-581
Loginova, S.I.; Borisevich, S.V.; Koval'chuk, A.V.; Shtabnaia, V.V.; Pashchenko, I.I.; Khamitov, R.A.; Maksimov, V.A. 2007: The in vitro antiviral activity against the causative agent of hemorrhagic fever with renal syndrome Voprosy Virusologii 52(4): 34-36
Leventhal, H 1984: Rewards and adolescent health behavior: Promise or promise missed Health Psychology 3(4): 347-349
Aksenov, V.A.; Selidovkin, D.A.; Gladkikh, G.N.; Grakhova, A.G.; Bogdanova, N.S. 1970: Evaluation of the preventive effectiveness in influenza of the new native antiviral chemical agent oxoline in the 1969 epidemics Farmakologiia i Toksikologiia 33(6): 726-733
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Amlacher, R. 1985: Route-dependent different relations between acute and subacute toxicity of the potential antiviral agent benzoxazolyl-2-formyl-S-ethyl-isothiosemicarbazone in mice Die Pharmazie 40(2): 132-133
Rouse, B.T.; Wardley, R.C.; Babiuk, L.A.; Mukkur, T.K. 1977: The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition Journal of Immunology 118(6): 1957-1961